No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Varithena is a brand of cardiovascular drug used to treat varicose veins. It is a foam-based sclerosant, which is injected into the affected veins to reduce their size and improve blood flow. The drug is approved by the U.S. Food and Drug Administration (FDA) and is available in the United States, Canada, and Europe. Varithena is manufactured by BTG International, a global healthcare company.
The Varithena market is composed of a variety of companies that offer products and services related to the treatment of varicose veins. These include medical device companies that manufacture and distribute the drug, as well as healthcare providers that offer the treatment. Additionally, there are companies that provide educational resources and support services to patients and healthcare professionals.
Some of the companies in the Varithena market include BTG International, AngioDynamics, Inc., Medtronic, Inc., and Vascular Solutions, Inc. Show Less Read more
